BlackRock Group LTD - LOXO ONCOLOGY INC ownership

LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 86 filers reported holding LOXO ONCOLOGY INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
BlackRock Group LTD ownership history of LOXO ONCOLOGY INC
ValueSharesWeighting
Q4 2016$217,000
+48.6%
6,729
+20.7%
0.00%
Q3 2016$146,000
+24.8%
5,574
+9.7%
0.00%
Q2 2016$117,000
-15.8%
5,079
-35.9%
0.00%
Q3 2015$139,000
-2.8%
7,9240.0%0.00%
Q2 2015$143,000
+88.2%
7,924
+29.4%
0.00%
Q1 2015$76,000
+5.6%
6,1220.0%0.00%
Q4 2014$72,0006,1220.00%
Other shareholders
LOXO ONCOLOGY INC shareholders Q4 2016
NameSharesValueWeighting ↓
Aisling Capital LLC 4,028,920$129,409,00030.09%
Casdin Capital, LLC 360,000$11,561,0009.55%
DAFNA Capital Management LLC 139,722$4,487,0003.94%
Opaleye Management Inc. 125,000$4,014,0002.36%
Eventide Asset Management 740,000$23,765,0001.55%
Crawford Lake Capital Management, LLC 52,713$1,693,0001.22%
AWM Investment Company, Inc. 180,000$5,781,0001.13%
Orbimed Advisors 1,728,000$55,495,0000.71%
DRIEHAUS CAPITAL MANAGEMENT LLC 423,276$13,594,0000.48%
EAM Investors, LLC 111,268$3,573,0000.48%
View complete list of LOXO ONCOLOGY INC shareholders